Neurocrine Biosciences Analyst Ratings

BenzingaMar 26 20:27 · Ratings

Direxion Daily S&P Biotech Bull 3X Shares Declares Quarterly Distribution of $0.10714

Seeking AlphaMar 26 01:38

$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today

BenzingaMar 25 22:30

Alnylam Pharmaceuticals Presents 'Convincing Multi-Billion Dollar Opportunity': Analyst Upgrades Stock

BenzingaMar 25 02:08

Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday

BenzingaMar 24 20:48

Alternative "AI" investment? Mizuho: This U.S. stock theme hides a trillion-dollar opportunity, and these companies are expected to benefit first.

① There is a $1 trillion opportunity brewing in the stock market, which is not AI, but another form of "AI" - Aging Intelligence; ② The Mizuho Securities USA team mentioned this alternative "AI" opportunity in last week's report. This USA team of the Japanese Institutions stated that the aging population in the USA is expected to create significant opportunities.

cls.cnMar 24 19:49